VIR4:05 PMVir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026Presentation / Abstract • Phase 2vir.bio
VIR4:05 PMVir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conferencevir.bio
VIR4:05 PMVir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Resultsvir.bio